The Motley Fool Discussion Boards

Previous Page

Investment Analysis Clubs / Macro Economic Trends and Risks


Subject:  Generic Drug Scams Date:  3/21/2019  1:40 PM
Author:  syke6 Number:  555258 of 575855

Eli Lilly is throwing a bone to diabetics struggling with the high the price of insulin by introducing a generic, cheaper, insulin:

This month, Eli Lilly and Company announced with some fanfare that it was manufacturing a generic version of its own best-selling insulin brand, Humalog, which it would sell for half off — $137.50 versus $275.

The "generic" Humalog is manufactured by the same company, in the same factory, using the same equipment as the branded version. The article points out that's like selling an iPhone without the white box and calling it "generic."

And here's why diabetics are being crushed by the high price of insulin in the first place:

But they’re struggling, in large part, because Lilly has raised the price of Humalog from $35 to $275 a vial since 2001.

Oh, and by the way:

In Germany, the list price of a vial of Humalog is about $55 — or $45 if you buy five at a time — and that includes some taxes and markup fees.
Copyright 1996-2020 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us